ACCURETIC (Parke-Davis Div of Pfizer Inc)
Welcome to the PulseAid listing for the ACCURETIC drug offered from Parke-Davis Div of Pfizer Inc. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Parke-Davis Div of Pfizer Inc |
| NON-PROPRIETARY NAME: | quinapril hydrochloride and hydrochlorothiazide |
| SUBSTANCE NAME: | QUINAPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1999-12-28 |
| END MARKETING DATE: | 0000-00-00 |
ACCURETIC HUMAN PRESCRIPTION DRUG Details:
| Item Description | ACCURETIC from Parke-Davis Div of Pfizer Inc |
| LABELER NAME: | Parke-Davis Div of Pfizer Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20; 12.5(mg/1; mg/1) |
| START MARKETING DATE: | 1999-12-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0071-0220_d2a9be08-66c2-4816-ab83-44597accaa34 |
| PRODUCT NDC: | 0071-0220 |
| APPLICATION NUMBER: | NDA020125 |
Other QUINAPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers:
